NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

RXST

RxSight Inc

Jul 03 • 03:59PM ET

13.05

Dollar change -0.09
Percentage change -0.68	%

Healthcare • Medical Devices • USA • NASD

Peers: STAA ALGN ICUI EW BSX MDT SYK TFX BAX XRAY

| Held by: VTI IWM VXF IWO VTWO SCHA XHE VHT DFAS FFOX

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.67	Insider Own	7.08%	Shs Outstand	40.59M	Perf Week	-1.36%
Market Cap	530.31M	Forward P/E	-	EPS next Y	-0.53	Insider Trans	-0.25%	Shs Float	37.76M	Perf Month	-17.46%
Enterprise Value	313.01M	PEG	-	EPS next Q	-0.17	Inst Own	92.02%	Short Float	13.14%	Perf Quarter	-50.04%
Income	-26.55M	P/S	3.58	EPS this Y	2.77%	Inst Trans	8.39%	Short Ratio	4.66	Perf Half Y	-61.40%
Sales	148.31M	P/B	1.90	EPS next Y	22.68%	ROA	-10.70%	Short Interest	4.96M	Perf YTD	-62.04%
Book/sh	6.88	P/C	2.31	EPS next 5Y	25.39%	ROE	-11.98%	52W High	58.23 -77.59%	Perf Year	-77.02%
Cash/sh	5.64	P/FCF	-	EPS past 3/5Y	26.50% -	ROIC	-9.14%	52W Low	12.53 4.15%	Perf 3Y	-7.58%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	83.64% 128.61%	Gross Margin	71.87%	Volatility	4.78% 5.05%	Perf 5Y	-
Dividend TTM	-	EV/Sales	2.11	EPS Y/Y TTM	46.68%	Oper. Margin	-24.85%	ATR (14)	0.76	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	11.65	Sales Y/Y TTM	46.69%	Profit Margin	-17.90%	RSI (14)	37.82	Recom	2.18
Dividend Gr. 3/5Y	- -	Current Ratio	12.68	EPS Q/Q	18.14%	SMA20	-6.13%	Beta	1.20	Target Price	21.18
Payout	-	Debt/Eq	0.04	Sales Q/Q	28.41%	SMA50	-10.09%	Rel Volume	0.87	Prev Close	13.14
Employees	498	LT Debt/Eq	0.04	Earnings	May 07 AMC	SMA200	-57.97%	Avg Volume	1.06M	Price	13.05
IPO	Jul 30, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	7.71% -0.49%	Trades		Volume	927,254	Change	-0.68%

Date	Action	Analyst	Rating Change	Price Target Change
May-19-25	Upgrade	Wells Fargo	Equal Weight → Overweight	$25
Apr-15-25	Initiated	Piper Sandler	Neutral	$18
Apr-09-25	Downgrade	UBS	Buy → Neutral	$16
Apr-04-25	Downgrade	JP Morgan	Overweight → Underweight	$40 → $17
Apr-03-25	Downgrade	BofA Securities	Buy → Underperform	$36 → $22
Dec-20-24	Downgrade	Stifel	Buy → Hold	$65 → $40
Dec-11-24	Downgrade	Wells Fargo	Overweight → Equal Weight	$56 → $42
Dec-06-24	Initiated	UBS	Buy	$52
Oct-29-24	Initiated	Jefferies	Buy	$72
Aug-20-24	Reiterated	Needham	Buy	$54 → $66
Aug-06-24	Reiterated	Needham	Buy	$75 → $54
May-07-24	Reiterated	BTIG Research	Buy	$61 → $72
Dec-13-23	Upgrade	Wells Fargo	Equal Weight → Overweight	$31 → $42
Dec-12-23	Initiated	Stifel	Buy	$40
Dec-04-23	Initiated	Morgan Stanley	Overweight	$36
Apr-13-23	Initiated	Oppenheimer	Outperform	$23
Dec-12-22	Downgrade	Wells Fargo	Overweight → Equal Weight	$20 → $14
Apr-08-22	Initiated	Needham	Buy	$18

Show Previous Ratings

Jul-04-25 11:40AM	FMS vs. RXST: Which Stock Is the Better Value Option? (Zacks)
Jun-18-25 11:40AM	KMDA vs. ACAD: Which Stock Is the Better Value Option? (Zacks)
11:40AM	FMS or RXST: Which Is the Better Value Stock Right Now? (Zacks)
May-31-25 05:59AM	Down Over 30%: Wells Fargo Says Now Is the Time to Load Up on These 2 Beaten-Down Stocks (TipRanks)
May-23-25 08:32AM	Do Options Traders Know Something About RxSight Stock We Don't? (Zacks)
04:10PM	Loading…
May-20-25 04:10PM	RxSight, Inc. to Participate in the Stifel 2025 Virtual Ophthalmology Forum (GlobeNewswire)
10:55AM	Wells Fargo Upgrades RxSight (RXST), Sees LAL Technology as Undervalued (Insider Monkey)
May-08-25 03:31AM	RxSight Inc (RXST) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Advances Amid ... (GuruFocus.com) -11.21%
May-07-25 11:04PM	RxSight, Inc. (RXST) Q1 2025 Earnings Call Transcript (Seeking Alpha) +6.81%
07:55PM	RxSight, Inc. (RXST) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	RxSight, Inc. Reports First Quarter 2025 Financial Results (GlobeNewswire)
May-01-25 10:01AM	CVRx (CVRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Apr-30-25 04:05PM	RxSight, Inc. to Present at the Bank of America Healthcare Conference (GlobeNewswire)
10:01AM	RxSight, Inc. (RXST) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Apr-23-25 04:05PM	RxSight, Inc. to Report First Quarter 2025 Financial Results on May 7, 2025 (GlobeNewswire)
11:46AM	Loading…
Apr-04-25 11:46AM	JP Morgan downgrades RxSight on market, competitive pressures (Investing.com)
09:40AM	Block upgraded, Nvidia downgraded: Wall Streets top analyst calls (TipRanks)
03:00AM	RxSight Inc (RXST) Q1 2025 Earnings Call Highlights: Strong Year-Over-Year Growth Amid Revised ... (GuruFocus.com)
Apr-03-25 10:39PM	Preliminary Q1 2025 Rxsight Inc Earnings Call (Thomson Reuters StreetEvents) -37.94%
05:57PM	?RxSight: Navigating Market Headwinds Amid Intensifying Competition (Downgrade) (Seeking Alpha)
03:54PM	RxSight, Inc. (RXST) Q1 2025 Preliminary Results Conference Call (Transcript) (Seeking Alpha)
12:59PM	RxSight Plunges 44% After Slashing 2025 Guidance; Bank of America Downgrades Stock (GuruFocus.com)
07:32AM	RxSight Warns On FY25 Revenue As Premium Cataract Market Faces Headwinds, Stock Plunges (Benzinga)
Apr-02-25 08:00PM	RxSight, Inc. Announces Preliminary First Quarter 2025 Revenue and Revised 2025 Guidance (GlobeNewswire)
Mar-28-25 03:59PM	Baird Q4 2024 Small/Mid Cap Growth Equity Commentary (Seeking Alpha)
Mar-25-25 04:05PM	RxSight, Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Feb-26-25 02:15AM	RxSight Inc (RXST) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... (GuruFocus.com)
Feb-25-25 05:55PM	RxSight, Inc. (RXST) Misses Q4 Earnings Estimates (Zacks)
04:05PM	RxSight, Inc. Reports Fourth Quarter and Full-Year 2024 Financial Results, Reaffirms 2025 Guidance (GlobeNewswire)
01:36AM	What To Expect From RxSight Inc (RXST) Q4 2024 Earnings (GuruFocus.com)
04:10PM	Loading…
Feb-11-25 04:10PM	RxSight, Inc. to Report Fourth Quarter Financial Results on February 25, 2025 (GlobeNewswire)
Jan-18-25 07:55AM	RxSight price target lowered to $43 from $66 at Needham (TipRanks)
Jan-12-25 09:30AM	RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and Operational Results and 2025 Guidance (GlobeNewswire)
Jan-02-25 04:05PM	RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-20-24 09:43AM	Do You Believe in the Long-Term Growth Potential of RxSight (RXST)? (Insider Monkey) -11.86%
Nov-20-24 12:00PM	RxSight (RXST) Upgraded to Buy: Here's What You Should Know (Zacks)
Nov-08-24 12:02PM	RxSight Inc (RXST) Q3 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic Market ... (GuruFocus.com) -5.59%
Nov-07-24 07:00PM	RxSight, Inc. (RXST) Reports Break-Even Earnings for Q3 (Zacks) -7.09%
04:05PM	RxSight, Inc. Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-06-24 07:16AM	What To Expect From RxSight Inc (RXST) Q3 2024 Earnings (GuruFocus.com) +5.80%
Oct-24-24 04:05PM	RxSight, Inc. to Report Third Quarter Financial Results on November 7, 2024 (GlobeNewswire)
Oct-15-24 06:10PM	RxSight, Inc. (RXST): A Visionary Small-Cap Stock Pick by Hedge Funds (Insider Monkey)
Oct-13-24 05:33PM	RxSight, Inc. (RXST): Top Investors Are Investing In This Small-Cap Stock Now (Insider Monkey)
Aug-22-24 04:05PM	RxSight, Inc. to Participate in Upcoming Morgan Stanley and Wells Fargo Healthcare Conferences (GlobeNewswire)
Aug-19-24 03:43PM	RxSight Stock Sees Relative Strength Rating Rise To 91 (Investor's Business Daily)
Aug-12-24 09:55AM	Does RxSight (RXST) Have the Potential to Rally 27.64% as Wall Street Analysts Expect? (Zacks)
Aug-06-24 09:55AM	Q2 2024 Rxsight Inc Earnings Call (Thomson Reuters StreetEvents) +17.34%
Aug-05-24 06:10PM	RxSight, Inc. (RXST) Reports Break-Even Earnings for Q2 (Zacks)
04:05PM	RxSight, Inc. Reports Second Quarter 2024 Financial Results (GlobeNewswire)
11:20AM	The 3 Best Med Tech Stocks to Buy Now (InvestorPlace)
Jul-29-24 09:35AM	Down -26.04% in 4 Weeks, Here's Why RxSight (RXST) Looks Ripe for a Turnaround (Zacks)
Jul-22-24 04:05PM	RxSight, Inc. to Report Second Quarter Financial Results on August 5, 2024 (GlobeNewswire)
Jul-12-24 09:35AM	RxSight (RXST) Loses -16.11% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Jul-10-24 10:59AM	Dow Flat As Nasdaq, S&P 500 Rise Again; Gold Stocks Rally, But These Growth Players Get Hit (Live Coverage) (Investor's Business Daily) -10.32%
Jun-18-24 01:50AM	Insider Sale: Director Julie Andrews Sells 15,625 Shares of RxSight Inc (RXST) (GuruFocus.com)
Jun-13-24 11:22AM	Eye Care Innovator In Buy Zone; 176% Growth Expected For IBD 50 Stock (Investor's Business Daily)
Jun-07-24 02:40PM	These 5 Companies Lost Money. Here's Why They're Still On The IBD 50. (Investor's Business Daily)
Jun-05-24 04:05PM	RxSight, Inc. To Participate in the Truist Securities Medtech Conference (GlobeNewswire)
May-30-24 04:00AM	Oculis Publishes Results of 2024 Annual General Meeting and Announces Appointments to its Board of Directors and Scientific Advisory Board (GlobeNewswire)
May-28-24 12:00PM	What Makes RxSight, Inc. (RXST) a Strong Momentum Stock: Buy Now? (Zacks)
May-24-24 11:40AM	Why Top-Rated Medtech RxSight Has 20/20 Vision And Is Seeing 50% Growth (Investor's Business Daily)
May-13-24 04:58PM	RxSight Raises $115 Million From Public Offering of Shares (MT Newswires)
04:05PM	RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares (GlobeNewswire)
May-08-24 09:15PM	RxSight, Inc. Announces Pricing of Public Offering of Common Stock (GlobeNewswire)
04:05PM	RxSight, Inc. Announces Proposed Public Offering of Common Stock (GlobeNewswire)
May-07-24 12:17PM	Wells Fargo Adjusts RxSight Price Target to $68 From $61, Maintains Overweight Rating (MT Newswires)
08:50AM	RxSight, Inc. (NASDAQ:RXST) Q1 2024 Earnings Call Transcript (Insider Monkey)
08:49AM	Needham Adjusts Price Target on RxSight to $75 From $64, Maintains Buy Rating (MT Newswires)
08:48AM	Oppenheimer Adjusts RxSight Price Target to $72 From $61, Maintains Outperform Rating (MT Newswires)
08:28AM	BTIG Adjusts Price Target on RxSight to $72 From $61, Maintains Buy Rating (MT Newswires)
06:42AM	Q1 2024 Rxsight Inc Earnings Call (Thomson Reuters StreetEvents)
04:26AM	RxSight Q1 Adjusted Loss Narrows, Revenue Rises (MT Newswires)
03:10AM	RxSight Inc (RXST) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ... (GuruFocus.com)
May-06-24 05:37PM	RxSight Inc (RXST) Surpasses Analyst Revenue Forecasts in Q1 2024 (GuruFocus.com)
05:06PM	Rxsight Insider Sold Shares Worth $2,405,872, According to a Recent SEC Filing (MT Newswires)
04:05PM	RxSight, Inc. Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-02-24 05:03PM	Rxsight Insider Sold Shares Worth $526,913, According to a Recent SEC Filing (MT Newswires) +5.17%
May-01-24 04:05PM	RxSight, Inc. to Present at the Bank of America Healthcare Conference (GlobeNewswire) +8.77%
Apr-22-24 04:05PM	RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024 (GlobeNewswire)
Apr-04-24 04:05PM	RxSight Announces Commercial Launch of its Newest Light Adjustable Lens , the LAL+ , and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting (GlobeNewswire) +6.08%
Mar-27-24 04:05PM	RxSight, Inc. to Participate in the 23rd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Feb-29-24 07:05PM	RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference (GlobeNewswire)
11:09AM	RxSight, Inc. (NASDAQ:RXST) Q4 2023 Earnings Call Transcript (Insider Monkey)
08:36AM	Q4 2023 Rxsight Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-28-24 04:38PM	RxSight Inc (RXST) Reports Significant Revenue Growth in Q4 and Full Year 2023 (GuruFocus.com)
04:05PM	RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Feb-14-24 04:05PM	RxSight, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024 (GlobeNewswire)
Jan-19-24 05:01PM	Director Shweta Maniar Sells 6,399 Shares of RxSight Inc (GuruFocus.com)
Jan-12-24 03:16PM	3 Stocks to Buy BEFORE They Become Household Names (InvestorPlace)
Jan-09-24 06:19PM	RxSight, Inc. (RXST) Just Overtook the 20-Day Moving Average (Zacks)
Jan-07-24 10:00AM	RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance (GlobeNewswire)
Dec-27-23 04:05PM	RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference (GlobeNewswire)
Nov-15-23 09:30AM	RxSight, Inc. (RXST) Recently Broke Out Above the 50-Day Moving Average (Zacks)
Nov-12-23 10:26AM	RxSight, Inc. (NASDAQ:RXST) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-10-23 07:42AM	Q3 2023 Rxsight Inc Earnings Call (Thomson Reuters StreetEvents) +6.22%
Nov-09-23 04:05PM	RxSight, Inc. Reports Third Quarter 2023 Financial Results (GlobeNewswire)
Nov-02-23 09:00AM	RxSight, Inc. Educational and Product Announcements for AAO 2023 (GlobeNewswire)
Oct-26-23 04:05PM	RxSight, Inc. to Report Third Quarter Financial Results on November 9, 2023 (GlobeNewswire) -5.43%
Sep-07-23 09:35AM	RxSight, Inc. (RXST) Crossed Above the 20-Day Moving Average: What That Means for Investors (Zacks)
Aug-23-23 04:05PM	RxSight, Inc. to Present at the Wells Fargo Healthcare Conference (GlobeNewswire)

RxSight, Inc. engages in the research, development, manufacture, and sale of light adjustable lenses and related capital equipment. It also commercializes adjustable intraocular lens (IOL) that is customized after cataract surgery. The company was founded on March 5, 1997 and is headquartered in Aliso Viejo, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Weinberg Eric	See remarks	Jun 02 '25	Option Exercise	3.93	188,002	738,848	195,351	Jun 03 06:18 PM
Thunen Shelley B	See remarks	Apr 14 '25	Option Exercise	4.34	7,792	33,806	38,354	Apr 15 08:57 PM
Fountain Tamara	Director	Mar 12 '25	Sale	25.71	7,000	180,002	24,793	Mar 13 04:46 PM
TAMARA R FOUNTAIN	Director	Mar 12 '25	Proposed Sale	25.71	7,000	180,002		Mar 12 04:02 PM
Maniar Shweta	Director	Jan 22 '25	Sale	30.87	3,519	108,618	7,383	Jan 27 04:40 PM
Maniar Shweta	Director	Jan 22 '25	Proposed Sale	30.87	3,519	108,618		Jan 22 03:56 PM
Corley Jesse Anderson	Director	Jan 16 '25	Buy	31.13	1,767	55,004	3,210	Jan 17 07:08 PM
Corley Jesse Anderson	Director	Jan 15 '25	Buy	31.18	1,443	45,000	1,443	Jan 17 07:08 PM
Goldshleger Ilya	See remarks	Nov 29 '24	Option Exercise	15.08	3,105	46,823	45,351	Dec 03 06:38 PM
Goldshleger Ilya	See remarks	Nov 29 '24	Sale	46.08	3,105	143,078	42,246	Dec 03 06:38 PM
ILYA GOLDSHLEGER	Officer	Nov 29 '24	Proposed Sale	46.08	3,105	143,078		Nov 29 01:29 PM
Maniar Shweta	Director	Nov 26 '24	Sale	45.88	3,782	173,518	10,902	Nov 26 07:26 PM
Goldshleger Ilya	See remarks	Nov 22 '24	Option Exercise	15.08	3,100	46,748	45,346	Nov 26 07:25 PM
Goldshleger Ilya	See remarks	Nov 26 '24	Option Exercise	15.08	3,100	46,748	45,346	Nov 26 07:25 PM
Goldshleger Ilya	See remarks	Nov 26 '24	Sale	45.88	3,100	142,228	42,246	Nov 26 07:25 PM
Goldshleger Ilya	See remarks	Nov 22 '24	Sale	45.00	3,100	139,500	42,246	Nov 26 07:25 PM
ILYA GOLDSHLEGER	Officer	Nov 26 '24	Proposed Sale	45.88	3,100	142,228		Nov 26 04:13 PM
Maniar Shweta	Director	Nov 26 '24	Proposed Sale	45.88	3,782	173,518		Nov 26 02:45 PM
ILYA GOLDSHLEGER	Officer	Nov 22 '24	Proposed Sale	45.00	3,100	139,500		Nov 22 04:15 PM
Goldshleger Ilya	See remarks	Nov 15 '24	Option Exercise	15.08	4,875	73,515	47,121	Nov 18 09:50 PM
Goldshleger Ilya	See remarks	Nov 18 '24	Option Exercise	15.08	3,100	46,748	45,346	Nov 18 09:50 PM
Goldshleger Ilya	See remarks	Nov 15 '24	Sale	46.00	4,875	224,250	42,246	Nov 18 09:50 PM
Goldshleger Ilya	See remarks	Nov 18 '24	Sale	45.00	3,100	139,502	42,246	Nov 18 09:50 PM
ILYA GOLDSHLEGER	Officer	Nov 18 '24	Proposed Sale	45.00	3,100	139,502		Nov 18 04:29 PM
ILYA GOLDSHLEGER	Officer	Nov 15 '24	Proposed Sale	46.00	4,875	224,250		Nov 15 04:18 PM
Goldshleger Ilya	See remarks	Nov 12 '24	Option Exercise	15.08	1,330	20,056	43,576	Nov 14 07:42 PM
Goldshleger Ilya	See remarks	Nov 12 '24	Sale	46.13	1,330	61,356	42,246	Nov 14 07:42 PM
Corley Jesse Anderson	Director	Nov 12 '24	Buy	45.37	11,111	504,079	468,571	Nov 14 07:14 PM
Corley Jesse Anderson	Director	Nov 13 '24	Buy	44.84	5,795	259,841	38,438	Nov 14 07:14 PM
Corley Jesse Anderson	Director	Nov 13 '24	Buy	45.00	5,570	250,650	474,141	Nov 14 07:14 PM
ILYA GOLDSHLEGER	Officer	Nov 12 '24	Proposed Sale	46.13	1,330	61,356		Nov 12 05:38 PM
Goldshleger Ilya	See remarks	Nov 07 '24	Option Exercise	15.08	3,100	46,748	45,346	Nov 08 04:00 PM
Goldshleger Ilya	See remarks	Nov 07 '24	Sale	55.00	3,100	170,495	42,246	Nov 08 04:00 PM
ILYA GOLDSHLEGER	Officer	Nov 07 '24	Proposed Sale	55.00	3,100	170,494		Nov 07 04:14 PM
Goldshleger Ilya	See remarks	Nov 04 '24	Option Exercise	15.08	3,100	46,748	45,346	Nov 05 04:05 PM
Goldshleger Ilya	See remarks	Nov 04 '24	Sale	51.05	3,100	158,247	42,246	Nov 05 04:05 PM
ILYA GOLDSHLEGER	Officer	Nov 04 '24	Proposed Sale	51.05	3,100	158,247		Nov 04 04:17 PM
Goldshleger Ilya	See remarks	Oct 30 '24	Option Exercise	15.08	3,105	46,823	45,351	Oct 31 05:22 PM
Goldshleger Ilya	See remarks	Oct 30 '24	Sale	51.91	3,105	161,171	42,246	Oct 31 05:22 PM
LYA GOLDSHLEGER	Officer	Oct 30 '24	Proposed Sale	51.91	3,105	161,171		Oct 30 04:28 PM
Goldshleger Ilya	See remarks	Oct 25 '24	Option Exercise	15.08	3,100	46,748	45,346	Oct 28 08:55 PM
Goldshleger Ilya	See remarks	Oct 28 '24	Option Exercise	15.08	3,100	46,748	45,346	Oct 28 08:55 PM
Goldshleger Ilya	See remarks	Oct 28 '24	Sale	50.64	3,100	156,993	42,246	Oct 28 08:55 PM
Goldshleger Ilya	See remarks	Oct 25 '24	Sale	49.79	3,100	154,360	42,246	Oct 28 08:55 PM
ILYA GOLDSHLEGER	Officer	Oct 28 '24	Proposed Sale	50.64	3,100	156,993		Oct 28 04:15 PM
ILYA GOLDSHLEGER	Officer	Oct 25 '24	Proposed Sale	49.79	3,100	154,360		Oct 25 04:15 PM
Goldshleger Ilya	See remarks	Oct 22 '24	Option Exercise	15.08	3,100	46,748	45,346	Oct 22 08:17 PM
Goldshleger Ilya	See remarks	Oct 22 '24	Sale	49.68	3,100	154,001	42,246	Oct 22 08:17 PM
ILYA GOLDSHLEGER	Officer	Oct 22 '24	Proposed Sale	49.68	3,100	154,001		Oct 22 04:16 PM
Goldshleger Ilya	See remarks	Oct 18 '24	Option Exercise	15.08	3,105	46,823	45,351	Oct 18 05:23 PM
Goldshleger Ilya	See remarks	Oct 16 '24	Option Exercise	15.08	3,100	46,748	45,346	Oct 18 05:23 PM
Goldshleger Ilya	See remarks	Oct 18 '24	Sale	50.09	3,105	155,533	42,246	Oct 18 05:23 PM
Goldshleger Ilya	See remarks	Oct 16 '24	Sale	49.78	3,100	154,318	42,246	Oct 18 05:23 PM
ILYA GOLDSHLEGER	Officer	Oct 18 '24	Proposed Sale	50.09	3,105	155,533		Oct 18 04:23 PM
ILYA GOLDSHLEGER	Officer	Oct 16 '24	Proposed Sale	49.78	3,100	154,317		Oct 16 04:16 PM
Goldshleger Ilya	See remarks	Oct 10 '24	Option Exercise	15.08	3,105	46,823	45,351	Oct 15 04:23 PM
Goldshleger Ilya	See remarks	Oct 11 '24	Option Exercise	15.08	3,100	46,748	45,346	Oct 15 04:23 PM
Goldshleger Ilya	See remarks	Oct 14 '24	Option Exercise	15.08	3,100	46,748	45,346	Oct 15 04:23 PM
Goldshleger Ilya	See remarks	Oct 11 '24	Sale	50.19	3,100	155,594	42,246	Oct 15 04:23 PM
Goldshleger Ilya	See remarks	Oct 14 '24	Sale	50.09	3,100	155,268	42,246	Oct 15 04:23 PM
Goldshleger Ilya	See remarks	Oct 10 '24	Sale	48.82	3,105	151,596	42,246	Oct 15 04:23 PM
ILYA GOLDSHLEGER	Officer	Oct 14 '24	Proposed Sale	50.09	3,100	155,268		Oct 15 08:23 AM
ILYA GOLDSHLEGER	Officer	Oct 11 '24	Proposed Sale	50.19	3,100	155,593		Oct 11 04:17 PM
ILYA GOLDSHLEGER	Officer	Oct 10 '24	Proposed Sale	48.82	3,105	151,595		Oct 10 04:11 PM
Goldshleger Ilya	See remarks	Oct 04 '24	Option Exercise	15.08	3,100	46,748	45,346	Oct 08 06:00 PM
Goldshleger Ilya	See remarks	Oct 08 '24	Option Exercise	15.08	3,100	46,748	45,346	Oct 08 06:00 PM
Goldshleger Ilya	See remarks	Oct 08 '24	Sale	48.26	3,100	149,612	42,246	Oct 08 06:00 PM
Goldshleger Ilya	See remarks	Oct 04 '24	Sale	48.01	3,100	148,824	42,246	Oct 08 06:00 PM
ILYA GOLDSHLEGER	Officer	Oct 08 '24	Proposed Sale	48.26	3,100	149,612		Oct 08 04:19 PM
ILYA GOLDSHLEGER	Officer	Oct 04 '24	Proposed Sale	48.01	3,100	148,824		Oct 04 04:23 PM
Thunen Shelley B	See remarks	Oct 01 '24	Option Exercise	16.00	15,000	240,000	45,443	Oct 02 04:11 PM
Thunen Shelley B	See remarks	Oct 01 '24	Sale	48.45	15,000	726,730	30,443	Oct 02 04:11 PM
SHELLEY B THUNEN	Officer	Oct 01 '24	Proposed Sale	48.45	15,000	726,729		Oct 01 04:24 PM
Goldshleger Ilya	See remarks	Sep 26 '24	Option Exercise	15.08	3,105	46,823	45,351	Sep 30 08:05 PM
Goldshleger Ilya	See remarks	Sep 30 '24	Option Exercise	15.08	3,100	46,748	45,346	Sep 30 08:05 PM
Goldshleger Ilya	See remarks	Sep 26 '24	Sale	49.29	3,105	153,054	42,246	Sep 30 08:05 PM
Goldshleger Ilya	See remarks	Sep 30 '24	Sale	49.02	3,100	151,947	42,246	Sep 30 08:05 PM
ILYA GOLDSHLEGER	Officer	Sep 30 '24	Proposed Sale	49.02	3,100	151,946		Sep 30 04:14 PM
ILYA GOLDSHLEGER	Officer	Sep 26 '24	Proposed Sale	49.29	3,105	153,054		Sep 26 04:09 PM
Goldshleger Ilya	See remarks	Sep 20 '24	Option Exercise	15.08	3,100	46,748	45,346	Sep 23 06:48 PM
Goldshleger Ilya	See remarks	Sep 23 '24	Option Exercise	15.08	3,100	46,748	45,346	Sep 23 06:48 PM
Goldshleger Ilya	See remarks	Sep 20 '24	Sale	53.19	3,100	164,901	42,246	Sep 23 06:48 PM
Goldshleger Ilya	See remarks	Sep 23 '24	Sale	52.67	3,100	163,263	42,246	Sep 23 06:48 PM
ILYA GOLDSHLEGER	Officer	Sep 23 '24	Proposed Sale	52.67	3,100	163,263		Sep 23 04:08 PM
ILYA GOLDSHLEGER	Officer	Sep 20 '24	Proposed Sale	53.19	3,100	164,901		Sep 20 04:08 PM
Goldshleger Ilya	See remarks	Sep 17 '24	Option Exercise	15.08	3,100	46,748	45,346	Sep 18 04:41 PM
Goldshleger Ilya	See remarks	Sep 17 '24	Sale	56.11	3,100	173,944	42,246	Sep 18 04:41 PM
ILYA GOLDSHLEGER	Officer	Sep 17 '24	Proposed Sale	56.11	3,100	173,943		Sep 17 04:15 PM
Kurtz Ronald M MD	President & CEO	Aug 09 '24	Option Exercise	12.60	9,950	125,355	63,450	Aug 09 05:57 PM
Goldshleger Ilya	See remarks	Aug 05 '24	Sale	39.25	9,000	353,291	42,246	Aug 06 04:19 PM
ILYA GOLDSHLEGER	Officer	Aug 05 '24	Proposed Sale	39.25	9,000	353,290		Aug 05 04:08 PM
Thunen Shelley B	See remarks	Jul 15 '24	Option Exercise	4.34	16,505	71,632	30,443	Jul 16 08:15 PM
Kurtz Ronald M MD	President & CEO	Jul 11 '24	Option Exercise	15.08	13,500	203,604	53,500	Jul 12 07:12 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

RXST

RxSight Inc

Upgrade your FINVIZ experience